100% agree i don't buy on such calls myself... but i do follow them as the language is always interesting - even if it is just a recap of what management are saying... they can always say a lot more interesting stuff in such one on one private meetings - whether it is honest, now that's another story!
On the court / FDA stuff - TRT is a real political issue - the direct to consumer TV advertising of these drugs got well out of hand and the ad campaigns have been significantly scaled down since the civil proceedings started and the FDA warnings... could be just coincidence here... but the companies do appear to be cautious
ACR Price at posting:
66.0¢ Sentiment: Hold Disclosure: Held
